Abstract:Abstract Cutaneous graft-versus-host disease (GVHD) is a well-recognized complication, occurring in 60–80% of patients after allogeneic bone marrow stem cell transplantation (BMSCT) (Garbutcheon-Singh KB, Fernández-Peñas P. Phototherapy for the treatment of cutaneous graft-versus-host disease. Australas J Dermatol 2015; 56: 93–9). The chronic type manifests as either a lichenoid or sclerodermatous form. Phototherapy is an effective treatment option as it works by immunomodulatory effects. We retrospectively reviewed eight cases of chronic cutaneous GVHD. All the patients had undergone allogeneic BMSCT for an underlying haematological disorder at a tertiary care centre in western India. Each patient was administered phototherapy with ultraviolet (UV)A radiation twice a week. All of them received 8-methoxypsoralen at a dose of 0.6 mg kg−1 as a photosensitizer, 2 h prior to UVA therapy. The percentage improvement in body surface area involved was calculated at the end of therapy and results were analysed using SPSS. Also, the doses of steroids and immunosuppressants were tapered while the patient was on phototherapy. A total of eight patients were enrolled in the study; five (63%) were male (63%) and three (38%) were female. The mean age at the time of presentation was 37.75 years. Five patients (63%) had lichenoid GVHD, while the other three cases (38%) had sclerodermatous type GVHD. Six patients had undergone allogeneic BMSCT for leukaemia, while one patient had myelofibrosis and one case was diagnosed with Diamond–Blackfan syndrome. The mean time to develop GVHD after bone marrow transplant was 9.5 months and the mean body surface area involved at the time of diagnosis was 50.6%. There was more than 50% improvement in five cases (63%) after an average of 36.3 sessions of psoralen plus UVA (PUVA), while one case (13%) relapsed after achieving complete remission. One patient (13%) was lost to follow-up as he was not able to visit the hospital frequently for twice-weekly sessions. One patient (13%) died while on PUVA therapy owing to relapse of leukaemia. Generally, all the patients tolerated PUVA well, except two patients who experienced nausea after taking psoralen, one patient with dizziness after PUVA therapy and one patient who complained of pigmentation of skin over the extremities. The percentage reduction in the dose of steroids before and after phototherapy was also found to be statistically significant. We conclude that PUVA therapy is an effective nonaggressive modality for treating chronic cutaneous GVHD, especially the lichenoid form. It offers a major advantage of an immunosuppressive sparing effect as well as a good safety profile.

Cutaneous Alternariosis in Immunosuppressed Patients Treated with Photodynamic Therapy and Oral Antifungals, a Synergistic Strategy

Potential Implications for Cutaneous Mycosis

Co-existence of Cutaneous Alternariosis and Tinea Corporis in a Renal Transplant Recipient.

Alternaria infections: laboratory diagnosis and relevant clinical features

Antimicrobial photodynamic therapy as treatment of infected oral ulcers in patients undergoing hematopoietic stem cell transplantation: Report of two cases

Antimicrobial Photodynamic Therapy in Combination with Nystatin in the Treatment of Experimental Oral Candidiasis Induced by Candida albicans Resistant to Fluconazole

Effectiveness of photodynamic therapy on treatment response and survival in patients with recurrent oral squamous cell carcinoma: a systematic review

Successful Sequential Treatment with Itraconazole and ALA-PDT for Cutaneous Granuloma by Candida albicans : A Case Report and Literature Review

Photodynamic Therapy Combined with Terbinafine Against Chromoblastomycosis and the Effect of PDT on Fonsecaea monophora In Vitro

Bath psoralen plus ultraviolet-A photochemotherapy for chronic graft-versus-host disease: a retrospective cohort study

Surgery Plus Photodynamic Therapy for a Diabetic Patient with Cutaneous Infectious Granuloma Caused by Curvularia Lunata.

Photobiomodulation therapy to prevent oral mucositis and functional impairment in adult patients with haematological cancer undergoing haematopoietic stem cell transplantation: randomised trial protocol

A Refractory Case of Chromoblastomycosis Due to Fonsecaea Monophora with Improvement by Photodynamic Therapy.

A Case of Pemphigoid Accompany with Cutaneous Alternariosis

BI37 Efficacy of psoralen plus ultraviolet A therapy for the treatment of chronic cutaneous graft-versus-host disease: a retrospective study analysis from a tertiary care centre

Combinatory effect of ALA-PDT and itraconazole in the treatment of cutaneous protothecosis

Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis

Photodynamic Therapy Combined with Antibiotics or Antifungals against Microorganisms That Cause Skin and Soft Tissue Infections: A Planktonic and Biofilm Approach to Overcome Resistances

Combination of photodynamic therapy and immunotherapy - evolving role in dermatology

Successful Application of Photodynamic Therapy for Skin Infection Caused by Corynespora Cassiicola in an Immunosuppressed Patient and Literature Review.

Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta‐analysis